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European Americans are often treated as a homogeneous group, but in fact form a structured population due to
historical immigration of diverse source populations. Discerning the ancestry of European Americans genotyped in
association studies is important in order to prevent false-positive or false-negative associations due to population
stratification and to identify genetic variants whose contribution to disease risk differs across European ancestries.
Here, we investigate empirical patterns of population structure in European Americans, analyzing 4,198 samples from
four genome-wide association studies to show that components roughly corresponding to northwest European,
southeast European, and Ashkenazi Jewish ancestry are the main sources of European American population structure.
Building on this insight, we constructed a panel of 300 validated markers that are highly informative for distinguishing
these ancestries. We demonstrate that this panel of markers can be used to correct for stratification in association
studies that do not generate dense genotype data.
Citation: Price AL, Butler J, Patterson N, Capelli C, Pascali VL, et al. (2008) Discerning the ancestry of European Americans in genetic association studies. PLoS Genet 4(1): e236.
doi:10.1371/journal.pgen.0030236
Introduction
European Americans are the most populous single ethnic
g r o u pi nt h eU n i t e dS t a t e saccording to U.S. census
categories, and are often sampled in genetic association
studies. European Americans are usually treated as a single
population (as are other groups such as African Americans,
Latinos, and East Asians), and the use of labels such as ‘‘white’’
or ‘‘Caucasian’’ can propagate the illusion of genetic
homogeneity. However, European Americans in fact form a
structured population, due to historical immigration from
diverse source populations. This can lead to population
stratiﬁcation—allele frequency differences between cases and
controls due to systematic ancestry differences—and to
ancestry-speciﬁc disease risks [1–5].
Previous studies have carefully analyzed the population
structure of Europe [6–8], but here our focus is on European
Americans, who constitute a non-random sampling of Euro-
pean ancestry that reﬂects the historical immigration
patterns of the United States. To understand European
American population structure as it pertains to association
studies, we used dense genotype data from four real genome-
wide association studies, analyzing European American
population samples from multiple locations in the U.S. We
found that in these samples, the most important sources of
population structure are (i) the distinction between north-
west European and either southeast European or Ashkenazi
Jewish ancestry (similar to the main genetic gradient within
Europe [6–8]) and (ii) the distinction between southeast
European and Ashkenazi Jewish ancestry (which is more
readily detectable in our European American data than in
previous studies involving Europeans [6–8]). These ancestries
can be effectively discerned using dense genotype data,
making it possible to correct for population stratiﬁcation and
to identify ancestry-speciﬁc risk loci in genome-wide associ-
ation studies [9].
Although genome-wide association studies that generate
dense genotype data are becoming increasingly practical,
targeted association studies—such as candidate gene studies
or replication studies following up genome-wide scans—will
continue to play a major role in human genetics. These
studies typically analyze a much smaller number of markers
than genome-wide scans, making it far more difﬁcult to infer
ancestry in order to correct for stratiﬁcation and identify
ancestry-speciﬁc risk loci. To address this, a possible strategy
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informative markers [10], and this is the approach we take in
the current paper. Using the insights from analyses of dense
genotype data in multiple European American sample sets,
we set out to identify markers informative for the ancestries
most relevant to European Americans. Important work has
already shown that northwest and southeast Europeans can
be distinguished using as few as 800–1,200 ancestry-informa-
tive markers mined from datasets of 6,000–10,000 markers
[7,8]. Here we mine much larger datasets (more markers and
more samples) to identify a panel of 300 highly ancestry-
informative markers which accurately distinguish not just
northwest and southeast European, but also Ashkenazi Jewish
ancestry. This panel of markers is likely to be useful in
targeted disease studies involving European Americans. In
particular, the panel is effective in inferring ancestry and
correcting a spurious association in a published example of
population stratiﬁcation in European Americans [1].
Results
Analysis of Data from Genome-Wide Association Studies
To investigate whether we could identify consistent
patterns of European American population structure, we
analyzed four European American datasets involving a total
of 4,198 samples. These samples were genotyped on the
Affymetrix GeneChip 500K or Illumina HumanHap300
marker sets in the context of genome-wide association
studies for multiple sclerosis (MS), bipolar disorder (BD),
Parkinson’s disease (PD) and inﬂammatory bowel disease
(IBD) (see Methods). For each dataset, we used the EIGEN-
SOFT package to identify principal components describing
the most variation in the data [11]. The top two principal
components for each dataset are displayed in Figure 1.
Strikingly, the results are very similar for each dataset, and
are similar to our previous results on a smaller dataset
involving the Affymetrix GeneChip 100K marker set [9],
suggesting that the main sources of population structure are
roughly consistent across European American sample sets.
We were able to characterize the main ancestry compo-
nents in the IBD dataset, because a subset of these individuals
self-reported their ancestry as northwest European, southeast
European or Ashkenazi Jewish (see Methods). (We use the
term ‘‘ancestry’’ for ease of presentation, but caution that
cultural or geographic identiﬁers do not necessarily corre-
spond to genetic ancestry.) We conclude that the top two
principal components of genetic ancestry in the IBD dataset
roughly correspond to a continuous cline from northwest to
southeast European ancestry and an orthogonal discrete
separation between Ashkenazi Jewish and southeast Euro-
pean ancestry (Figure 1E). [We note that the northwest-
southeast axis corresponds approximately to the top princi-
pal component (x-axis in Figure 1), but this correspondence is
not exact, as principal components are mathematically
deﬁned to extract the most variance from the data without
regards to geographic interpretation. Thus, top principal
components will often represent a linear combination of
ancestry effects in the data.] Our results are consistent with a
previous study in which Ashkenazi Jewish and southeast
European samples occupied similar positions on the north-
west-southeast axis, although there was insufﬁcient data in
that study to separate these two populations [7]. A historical
interpretation of this ﬁnding is that both Ashkenazi Jewish
and southeast European ancestries are derived from migra-
tions/expansions from the Middle East and subsequent
admixture with existing European populations [12,13].
To determine whether the visually similar patterns ob-
served in these four datasets each represent the same
underlying components of ancestry, we constructed a
combined dataset of MS, BD, PD and IBD samples using
markers present in all datasets. The top two principal
components of the combined dataset, displayed in Figure 2,
are similar to the plots in Figure 1 and show the same rough
correspondence to self-reported ancestry labels from the IBD
study.
To simplify the assessment of ancestries represented in
each dataset, we discretely assigned each sample to cluster 1
(mostly northwest European), cluster 2 (mostly southeast
European), or cluster 3 (which contains the great majority of
self-reported Ashkenazi Jewish samples) based on proximities
to the center of each cluster in Figure 2 (see Methods). We
emphasize that this discrete approximation does not fully
capture the continuous northwest-southeast cline described
by the data, and that we are classifying genetic ancestry rather
than cultural or geographic identiﬁers—for example, not all
self-reported Ashkenazi Jewish samples lie in cluster 3.
Proportions of individuals assigned to each cluster are listed
in Table 1. Results are generally consistent with demographic
data indicating that 6% of the U.S. population self-reports
Italian ancestry and 2% of the U.S. population self-reports as
Ashkenazi Jewish, with higher representation of these groups
in urban areas [14,15]. We note that although the self-
reported ancestry of samples in the IBD dataset is generally
fairly consistent with the cluster assignments, Figure 2
indicates that inferred genetic ancestry is more nuanced
and informative than self-reported ancestry with regard to
genetic similarity, particularly for individuals who may
descend from multiple ancestral populations. By coloring
each plot in Figure 1 with cluster assignments inferred from
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Author Summary
Genetic association studies analyze both phenotypes (such as
disease status) and genotypes (at sites of DNA variation) of a given
set of individuals. The goal of association studies is to identify DNA
variants that affect disease risk or other traits of interest. However,
association studies can be confounded by differences in ancestry.
For example, misleading results can arise if individuals selected as
disease cases have different ancestry, on average, than healthy
controls. Although geographic ancestry explains only a small
fraction of human genetic variation, there exist genetic variants
that are much more frequent in populations with particular
ancestries, and such variants would falsely appear to be related to
disease. In an effort to avoid these spurious results, association
studies often restrict their focus to a single continental group.
European Americans are one such group that is commonly studied
in the United States. Here, we analyze multiple large European
American datasets to show that important differences in ancestry
exist even within European Americans, and that components
roughly corresponding to northwest European, southeast European,
and Ashkenazi Jewish ancestry are the major, consistent sources of
variation. We provide an approach that is able to account for these
ancestry differences in association studies even if only a small
number of genes is studied.Figure 1. The Top Two Axes of Variation of MS, BD, PD, and IBD Datasets
(A) MS dataset, (B) BD dataset, (C) PD dataset, (D) IBD dataset, (E) IBD dataset with samples labeled according to self-reported ancestry (see Methods):
northwest European (IBD-NWreport), southeast European (IBD-SEreport) or Ashkenazi Jewish (IBD-AJreport), with individuals having unknown or mixed
European ancestry and not self-reporting as Ashkenazi Jewish (IBD-noreport) not displayed.
doi:10.1371/journal.pgen.0030236.g001
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Discerning the Ancestry of European Americansthe combined dataset, we verify that the most important
ancestry effects in each individual dataset correspond to
these clusters (Figure S1).
We computed FST statistics between clusters 1 (mostly NW),
2 (mostly SE) and 3 (mostly AJ), restricting our analysis to
individuals unambiguously located in the center of each
cluster (Figure 2). We obtained FST(1,2) ¼ 0.005, FST(2,3) ¼
0.004 and FST(1,3) ¼ 0.009. The additivity of these variances
(0.005 þ 0.004 ¼ 0.009) would be consistent with the drift
distinguishing clusters 1 and 2 having occurred independ-
ently of the drift distinguishing clusters 2 and 3, as might be
expected under a hypothesis of drift speciﬁc to Ashkenazi
Jews due to founder effects [13,16]. However, more extensive
investigation will be required to draw deﬁnitive conclusions
about the demographic histories of these populations.
Impact of European American Population Structure on
Genetic Association Studies
To assess the extent to which ancestry differences across
sample sets could lead to population stratiﬁcation in real
genetic association studies, we computed association test
statistics across the genome, assigning differently ascertained
European American sample sets as cases and controls. We
ﬁrst compared the two Affymetrix 500K datasets, treating MS
samples as cases and BD samples as controls. (We did not
compare the two 300K datasets, which would lead to severe
stratiﬁcation because the IBD dataset was speciﬁcally ascer-
tained to include roughly equal numbers of Jewish and non-
Jewish samples.) To minimize the effects of assay artifacts [17]
on our computations, we applied very stringent data quality
ﬁlters (see Methods). We computed values of k, a metric
describing genome-wide inﬂation in association statistics [18],
both before or after correcting for stratiﬁcation using the
EIGENSTRAT method [9]. We used the combined dataset to
infer population structure, ensuring that the top two
eigenvectors correspond to northwest European, southeast
European and Ashkenazi Jewish ancestry (Figure 2). Values of
k after correcting along 0, 1, 2 or 10 eigenvectors are listed in
Table 2, and demonstrate that the top two eigenvectors
correct nearly all of the stratiﬁcation that can be corrected
using 10 eigenvectors, with all of the correction coming from
the ﬁrst eigenvector; the second eigenvector has no effect
because the ratio of cluster 2 (SE) to cluster 3 (AJ) samples is
the same in the MS and BD datasets (Table 1). Residual
stratiﬁcation beyond the top 10 eigenvectors is likely to be
due to extremely subtle assay artifacts that EIGENSTRAT
cannot detect – indeed, with less stringent data quality ﬁlters
(see Methods) the value of k after correcting for the top 10
eigenvectors increases to 1.090, instead of 1.035.
The BD dataset contains two distinct subsamples (one
collected from Pittsburgh and one collected from throughout
the U.S.). Thus, we repeated the above experiment using
Pittsburgh samples as cases and other U.S. samples as controls
and assessed the level of stratiﬁcation. According to the
discrete classiﬁcation described above, proportions of clus-
ters 1/2/3 ancestry were 91%/8%/2% for Pittsburgh samples
vs. 95%/2%/3% for other U.S. samples, thus we would expect
differences along the second axis of variation, which
distinguishes clusters 2 and 3, to contribute to stratiﬁcation.
Indeed, results in Table 3 show that correcting along the
second eigenvector has an important effect in this analysis,
and that the top two eigenvectors correct for most of the
stratiﬁcation that can be corrected using 10 eigenvectors.
These results suggest that discerning clusters 1, 2 and 3,
which roughly correspond to northwest European, southeast
European and Ashkenazi Jewish ancestry, is sufﬁcient to
correct for most population stratiﬁcation in genetic associ-
Table 2. Values of Genome-Wide Inflation Factor (k) for Two
Comparisons of Genome-Wide Datasets, Correcting along 0, 1, 2,
or 10 Eigenvectors Using EIGENSTRAT
Datasets 0 Eigen-
vectors
1 Eigen-
vector
2 Eigen-
vectors
10 Eigen-
vectors
MS versus BD 1.144 1.049 1.049 1.035
BD-P versus BD-U 1.154 1.091 1.048 1.014
The second comparison is of BD samples from Pittsburgh (BD-P) versus BD samples from
throughout the U.S. (BD-U).
doi:10.1371/journal.pgen.0030236.t002
Table 1. Inferred Ancestry of Individuals in the MS, BD, PD, and
IBD Datasets
Dataset Number of
Samples
Cluster 1
(NW)
Cluster 2
(SE)
Cluster 3
(AJ)
MS 985 804 (82%) 110 (11%) 71 (7%)
BD 1,636 1,531 (94%) 63 (4%) 42 (3%)
PD 531 474 (89%) 26 (5%) 31 (6%)
IBD-noreport 399 346 (87%) 49 (12%) 4 (1%)
IBD-NWreport 103 98 (95%) 3 (3%) 2 (2%)
IBD-SEreport 4 1 (25%) 3 (75%) 0 (0%)
IBD-AJreport 388 13 (3%) 7 (2%) 368 (95%)
IBD samples are categorized according to self-reported ancestry: unknown or mixed
European ancestry and not self-reporting as Ashkenazi Jewish (IBD-noreport), northwest
European (IBD-NWreport), southeast European (IBD-SEreport) or Ashkenazi Jewish (IBD-
AJreport).
doi:10.1371/journal.pgen.0030236.t001
Figure 2. The Top Two Axes of Variation of the Combined Dataset (MS,
BD, PD, and IBD)
Samples from the IBD dataset are labeled according to self-reported
ancestry, as in Figure 1E.
doi:10.1371/journal.pgen.0030236.g002
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Discerning the Ancestry of European Americansation studies in European Americans. However, this does not
imply that these ancestries account for most of the
population structure throughout Europe, as there are many
European populations – such as Russians and other eastern
Europeans – that are not heavily represented in the United
States [14]. On the contrary, these results, along with the
results that follow, are entirely speciﬁc to European Amer-
icans.
Validation of a Panel of Ancestry-Informative Markers for
European Americans
To develop a small panel of markers sufﬁcient to
distinguish clusters 1, 2 and 3 in targeted association studies
in European Americans, we used several criteria to select 583
unlinked SNPs as potentially informative markers for within-
Europe ancestry (see Methods). These criteria included: (i)
Subpopulation differentiation between clusters 1 and 2, as
inferred from European American genome-wide data; (ii)
Subpopulation differentiation between clusters 2 and 3, as
inferred from European American genome-wide data; and
(iii) Signals of recent positive selection in samples of
European ancestry, which can lead to intra-European
variation in allele frequency [19,20]. As we describe below,
from these markers we identiﬁed a subset of 300 validated
markers that effectively discern clusters 1, 2 and 3.
To assess the informativeness of the initial 583 markers for
within-Europe ancestry, we genotyped each marker in up to
667 samples from 7 countries: 180 Swedish, 82 UK, 60 Polish,
60 Spanish, 124 Italian, 80 Greek and 81 U.S. Ashkenazi
Jewish samples (see Methods). We applied principal compo-
nents analysis to this dataset using the EIGENSOFT package
[11]. Results are displayed in Figure 3A, which clearly
separates the same three clusters, roughly corresponding to
northwest European, southeast European and Ashkenazi
Jewish ancestry, as in our analysis of genome-wide datasets
(Figure 2). We note that Spain occupies an intermediate
position between northwest and southeast Europe, while
Poland lies close to Sweden and UK, supporting a recent
suggestion that the northwest-southeast axis could alterna-
tively be interpreted as a north-southeast axis [8].
Deﬁning clusters 1, 2 and 3 based on membership in the
underlying populations, we computed FST(1,2) and FST(2,3)
for each marker passing quality control ﬁlters, and selected
100 markers with high FST(1,2) and 200 markers with high
FST(2,3) to construct a panel of 300 validated markers (see
Methods and Web Resources). We reran principal compo-
nents analysis on the 667 samples using only these 300
markers, and obtained results similar to before (Figure 3B).
The 300 markers have an average FST(1,2) of 0.07 for the 100
cluster 1 vs. 2 markers and an average FST(2,3) of 0.04 for the
200 cluster 2 vs. 3 markers. These FST values are biased
upward since they were computed using the same samples
that we used to select the 300 markers from the initial set of
583 markers. However, unbiased computations indicate an
average FST(1,2) of 0.06 for the 100 cluster 1 vs. 2 markers and
average FST(2,3) of 0.03 for the 200 cluster 2 vs. 3 markers,
indicating that the upward bias is modest (see Methods).
Recent work in theoretical statistics implies that the
squared correlation between an axis of variation inferred
with a limited number of markers and a true axis of variation
(e.g. as inferred using genome-wide data) is approximately
equal to x/(1þx), where x equals FST times the number of
markers (see Text S1) [21,11]. Thus, correlations will be on the
order of 90% for clusters 1 vs. 2 and 90% for clusters 2 vs. 3,
corresponding to a clear separation between the clusters
(Figure 3B). Because FST is typically above 0.10 for different
Figure 3. The Top Two Axes of Variation of a Dataset of Diverse European Samples
Results are based on (A) 583 markers putatively ancestry-informative markers, and (B) 300 validated markers.
doi:10.1371/journal.pgen.0030236.g003
Table 3. Association Statistics between LCT Candidate Marker
and Height in 368 European American Samples, before and after
Stratification Correction Using Our Panel of 300 Markers
Before or After Stratification v
2 Statistic P-Value
Before stratification correction 8.43 0.0037
After stratification correction 2.45 0.12
doi:10.1371/journal.pgen.0030236.t003
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Discerning the Ancestry of European Americanscontinental populations, it also follows that these 300
markers (which were not ascertained to be informative for
continental ancestry) will be sufﬁcient to easily distinguish
different continental populations, as we veriﬁed using
HapMap [22] samples (Figure S2). Thus, it will also be
possible to use these markers to remove genetic outliers of
different continental ancestry.
Correcting for Population Stratification in an Empirical
Targeted Association Study
To empirically test how effectively the panel of 300 markers
corrects for stratiﬁcation in real case-control studies, we
genotyped the panel in 368 European American samples
discordant for height, in which we recently demonstrated
stratiﬁcation [1]. In that study, we observed a strong
association (P-value , 10
 6) in 2,189 samples between height
and a candidate marker in the lactase (LCT) gene; this
association would be statistically signiﬁcant even after
correcting for the hundreds of markers typically genotyped
in a targeted association study (or in Bayesian terms,
incorporating an appropriate prior probability of associa-
tion). We concluded based on several lines of evidence that
the association was due to stratiﬁcation—in particular, both
LCT genotype and height track with northwest versus
southeast European ancestry. We focused our attention on
a subset of 368 samples and observed that after genotyping
178 additional markers on these samples, stratiﬁcation could
not be detected or corrected using standard methods [1].
Encouragingly, the panel of 300 markers detects and
corrects for stratiﬁcation in these 368 height samples. We
applied the EIGENSTRAT program [9] with default param-
eters to this dataset, together with ancestral European
samples, using the 299 markers unlinked to the candidate
LCT locus to infer ancestry and correct for stratiﬁcation (see
Methods). We note that it is important to exclude markers
linked to the candidate locus when inferring ancestry using a
small number of markers, to avoid a loss in power when
correcting for stratiﬁcation [9]. A plot of the top two axes of
variation is displayed in Figure 4, with height samples labeled
by self-reported grandparental origin (NW Europe, SE
Europe, or four USA-born grandparents) as described in
the height study [1]. Unsurprisingly, nearly all Height-
NWreport samples lie in cluster 1, which corresponds to
northwest European ancestry. More interestingly, nearly all
Height-USAreport samples also lie in cluster 1; because
clusters 2 and 3 do not seem to be represented in the ancestry
of USA-born grandparents of living European Americans, the
contribution of these clusters to the ancestry of living
European Americans may largely descend from foreign-born
grandparents, implying relatively recent immigration. Finally,
Height-SEreport samples lie in clusters 1, 2 and 3, indicating
that self-reported ancestry does not closely track the genetic
ancestry of these samples.
We detected stratiﬁcation between tall and short samples,
with the top two axes of variation explaining 5.1% of the
variance in height (P-value ¼ 9 3 10
 5). Furthermore, the top
two axes of variation explain 22% of the variance of the
candidate LCT marker (P-value ¼ 3 3 10
 18), indicating that
the association of the candidate marker to height is affected
by stratiﬁcation. Indeed, the observed association is no longer
signiﬁcant after correcting for stratiﬁcation (Table 3). The
residual trend towards association (P-value ¼ 0.12) could be
due to chance, to other axes of variation (besides those
corresponding to clusters 1, 2 and 3) which the panel of 300
m a r k e r sd o e sn o tc a p t u r e ,o rt oav e r ym o d e s tt r u e
association between LCT and height. Our results on
genome-wide datasets and on the height dataset suggest that
other axes of variation are much less likely to contribute to
stratiﬁcation in European Americans than the main axes we
have described. However, the possibility remains that other
axes, which are not captured by this panel of 300 markers,
could contribute to stratiﬁcation in some studies.
A recent study reported a successful correction for
stratiﬁcation in the height study using data from the 178
markers that were originally genotyped, using a ‘‘stratiﬁca-
tion score’’ method [23]. We investigated why the stratiﬁca-
tion score method succeeded while methods such as STRAT
and EIGENSTRAT are unable to correct for stratiﬁcation
using the same data [24,9,1]. The stratiﬁcation score method
computes regression coefﬁcients which describe how geno-
types of non-candidate markers predict disease status, uses
those regression coefﬁcients to estimate the odds of disease of
each sample conditional on genotypes of non-candidate
markers, and stratiﬁes the association between candidate
marker and disease status using the odds of disease (which
ostensibly varies due to ancestry). Importantly, the disease
status of each sample is included in the calculation of the
regression coefﬁcients that are subsequently used to estimate
the odds of disease of that sample. If the number of samples is
comparable to the number of markers, then each sample’s
disease status will substantially inﬂuence the set of regression
coefﬁcients used to compute the odds of disease of that
sample, so that the odds of disease will simply overﬁt the
actual disease status, leading to a large loss in power – even if
there is no correlation between disease status and ancestry
(see Text S1 and Tables S2 and S3). Thus, we believe that
informative marker sets are still needed to allow a fully
powered correction for stratiﬁcation in targeted studies such
as the height study.
Figure 4. The Top Two Axes of Variation of the Height Samples Together
with European Samples
Results are based on the 299 markers from our marker panel that are
unlinked to the LCT locus. Height samples are labeled according to self-
reported grandparental origin: northwest European (Height-NWreport),
southeast European (Height-SEreport) or four USA-born grandparents
(Height-USAreport).
doi:10.1371/journal.pgen.0030236.g004
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Discerning the Ancestry of European AmericansIt is important to point out that the panel of 300 markers
provides a better correction for stratiﬁcation than self-
reported ancestry, even for a study in which the ancestry
information is more extensive than is typically available.
Although the association between the LCT candidate marker
and height is reduced in the 368 samples when self-reported
grandparental origin is taken into account, it is not
eliminated (P-value ¼ 0.03). This is a consequence of the fact
that grandparental origin explains only 3.2% of the variance
in height and 17% of the variance of the candidate marker,
both substantially less than is explained by ancestry inferred
from the panel of 300 markers. These results provide further
evidence that genetically inferred ancestry can provide useful
information above and beyond self-reported ancestry [25].
We wondered whether using only the 100 markers chosen
to be informative for NW vs. SE ancestry would be sufﬁcient
to correct for stratiﬁcation in the height data. The top axis of
variation inferred from these markers explains 19% of the
variance of the candidate marker, but only 3.6% of the
variance in height. Because this axis captures most of the
variation attributable to ancestry at the candidate marker,
stratiﬁcation correction is almost as effective as before (P-
value ¼ 0.08). However, this axis is not fully effective in
capturing variation attributable to ancestry in height,
because it does not separate clusters 2 and 3 – we observed
that samples in cluster 2 are strongly biased towards shorter
height but samples in cluster 3 show no bias in height in this
dataset (data not shown). Thus, although the 100 NW vs. SE
markers may be sufﬁcient to correct for stratiﬁcation in some
instances, associations in European American sample sets
between other candidate loci and height could be affected by
stratiﬁcation unless the full panel of 300 markers is used.
More generally, the complete panel of 300 markers should
enable effective correction for stratiﬁcation in most targeted
association studies involving European Americans.
Discussion
We have analyzed four different genome-wide datasets
involving European American samples, and demonstrated
that the same two major axes of variation are consistently
present in each dataset. The ﬁrst major axis roughly
corresponds to a geographic axis of northwest-southeast
European ancestry, with Ashkenazi Jewish samples tending to
cluster with southeastern European ancestry; the second
major axis largely distinguishes Ashkenazi Jewish ancestry
from southeastern European ancestry. We identiﬁed and
validated a small panel of 300 informative markers that can
reliably discern these axes, permitting correction for the
major axes of ancestry variation in European Americans even
when genome-wide data is not available. We note that while
we have corrected for stratiﬁcation using our EIGENSTRAT
method, the panel of markers is not speciﬁc to this method,
and the STRAT method [24] or other structured association
approaches could similarly take advantage of this resource.
Our success in building a panel of markers informative for
within-Europe ancestry relied on multiple complementary
strategies for ascertaining markers. All strategies were
successful in identifying informative markers. We particularly
emphasize the success of applying principal components
analysis to genome-wide data from European American
samples and selecting markers highly differentiated along
top axes of variation. This strategy was the source of most of
our markers, and will become even more effective as datasets
with larger numbers of samples become available, enabling
further improvements to the panel and ascertainment of
markers to address stratiﬁcation in other populations.
The panel of 300 markers informative for within-Europe
ancestry is practical for genotyping in a small-scale study, and
permits correction for population stratiﬁcation in European
Americans at a very small fraction of the cost of a genome-
wide scan. We envision three applications:
1. The panel can be used to evaluate study design prior to a
genome-wide association study. By randomly choosing a few
hundred prospective cases and controls and genotyping them
on this panel, one can statistically determine whether or not
cases and controls are well matched for ancestry in the overall
study. If they are poorly matched, then properly matched
cases and controls for the study can be ascertained by
genotyping all cases and all controls using this panel (see Text
S1).
2. The panel can be genotyped in a targeted association
study, such as a candidate gene study or a replication study
following up a genome-wide association study, in which
variants are targeted in large numbers of samples that have
not been densely genotyped. The data from markers in the
panel can be used to correct for stratiﬁcation using methods
such as EIGENSTRAT [9], to ensure that observed associa-
tions are not spurious. This will also make it possible to
search for loci whose disease risk is ancestry-speciﬁc [26],
without relying on self-reported ancestry.
3. The panel can be used to remove genetic outliers and
assess genotyping quality of samples in a targeted association
study. Although the panel was not ascertained for evaluating
continental ancestry, it is sufﬁciently informative to identify
samples with different continental ancestry (Figure S2). It can
also be used to identify duplicate or cryptically related
samples.
Though we have focused here on the importance of
inferring ancestry in association studies, the panel of markers
may prove useful in a broad range of medical and forensic
applications.
Materials and Methods
Analysis of data from genome-wide association studies. The MS
dataset consists of 1,018 European American parents of individuals
with MS that were genotyped at Affymetrix GeneChip 500K markers
as part of a trio-design genome-wide scan for multiple sclerosis; most
of the individuals (.85%) were sampled from San Francisco. The BD
dataset consists of 1,727 European American controls that were
genotyped at Affymetrix GeneChip 500K markers as part of a
genome-wide scan for bipolar disorder; 1,229 individuals were
sampled from throughout the U.S. and 498 were sampled from
Pittsburgh. The PD dataset consists of 541 European Americans (270
cases and 271 controls) that were genotyped at Illumina Human-
Hap300 markers as part of a genome-wide scan for Parkinson’s
disease [27,28]; individuals were sampled from unspeciﬁed locations.
The IBD dataset consists of 912 European American controls from
the New York Health Project and U.S. Inﬂammatory Bowel Disease
Consortium that were genotyped at Illumina HumanHap300 markers
as part of a genome-wide scan for Inﬂammatory Bowel Disease. [A
subset of these samples self-reported their ancestry by indicating one
or more of the following: ‘‘Scandinavian’’, ‘‘Northern European’’,
‘‘Central European’’, ‘‘Eastern European’’, ‘‘Southern European’’,
‘‘East Mediterranean’’,o r‘‘Ashkenazi Jewish’’; we simpliﬁed this
classiﬁcation as follows: individuals indicating one or more of
‘‘Scandinavian’’, ‘‘Northern European’’,o r‘‘Central European’’ with
no other ancestries were reclassiﬁed as ‘‘IBD-NWreport’’, individuals
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pean’’,o r‘‘East Mediterranean’’ with no other ancestries were
reclassiﬁed as ‘‘IBD-SEreport’’, individuals indicating ‘‘Ashkenazi
Jewish’’ were reclassiﬁed as ‘‘IBD-AJreport’’ regardless of other
ancestries, and remaining individuals (either unknown or mixed
European ancestry and not self-reporting as Ashkenazi Jewish) were
reclassiﬁed as ‘‘IBD-noreport’’.] In each of the four datasets, we
removed markers with .5% missing genotypes, markers in regions of
extended linkage disequilibrium detected as principal components
[29], and outlier samples identiﬁed by principal components analysis
[9]. Analysis of the combined dataset was restricted to ;50,000
markers present in all datasets after applying these constraints.
Assignment of samples to three discrete clusters in combined
genome-wide dataset. Although the discrete approximation does not
fully capture the continuous northwest-southeast cline described by
the data, to simplify our analysis we assigned samples to three discrete
clusters so as to minimize distances to centers of clusters, deﬁned as
(0.01,0.01) for cluster 1, ( 0.02,–0.06) for cluster 2 and ( 0.04,0.01) for
cluster 3 (Figure 2).
Impact of European American population structure on genetic
association studies. In association analyses involving the MS and BD
datasets, we excluded markers that had .1% missing genotypes, or
failed Hardy-Weinberg equilibrium (P-value , 0.001), or had a low
minor allele frequency (,5%), in either the MS or BD datasets.
Roughly 200,000 of the Affymetrix 500K markers remained after
imposing these strict constraints. We also repeated our computations
with less stringent data quality ﬁlters (,5% missing data, instead of
,1%).
Genome-wide datasets used to ascertain ancestry-informative
markers. Genome-wide genotype data used to ascertain markers
included the MS, BD, PD and IBD datasets described above, plus three
additional European American datasets: a previously described
dataset of 488 samples with rheumatoid arthritis (RA) genotyped at
Affymetrix GeneChip 100K markers [9], a dataset of 305 unrelated
controls from the Framingham Heart Study (FHS) genotyped at
Affymetrix GeneChip 100K markers, and a dataset of 297 samples
with lung cancer (LC) genotyped at Affymetrix Sty 250K markers.
Data from HapMap [22] was also used.
Ascertainment of putatively ancestry-informative markers.
Markers were ascertained using multiple methods: (i) 185 markers
highly differentiated along the top axis of variation in genome-wide
datasets. Differentation was deﬁned as the correlation between
genotype and coefﬁcient along the top axis of variation, with a
correction for sample size. (ii) 300 markers highly differentiated
between individuals discretely assigned to cluster 2 (SE) or cluster 3
(AJ) in genome-wide datasets. Differentiation was measured using FST,
with a correction for sample size. (iii) 112 markers from regions of
high pexcess [30] between Europeans and non-Europeans in HapMap
[22] data. Regions of high pexcess were identiﬁed as windows of
consecutive markers with average pexcess values above 0.4, 0.5 or 0.6,
comparing allele frequencies in the CEU sample with the pooled
YRIþHCBþJPT sample. Within each of the longest such windows, a
marker was selected with the highest FST and a higher derived allele
frequency in CEU than in the other populations. (iv) 30 markers that
were both in the top 1% of the genome for iHH (integrated
haplotype homozygosity, a test of recent natural selection) as
reported in [19], and also at least 3 standard deviations above the
mean in differentiation between European and Asian samples from
HapMap. (v) 30 markers that were both in the top 1% of the genome
for iHH as reported in [19], and also part of a large stretch of the
genome with high iHH (at least two adjacent 100kb regions, as
reported in [19]). (vi) 31 markers from our published African
American admixture map [30] which in unpublished genotyping
results were highly differentiated between European populations
from Baltimore, Chicago, Utah, Italy, Norway and Poland, based on
the top two axes of variation. (vii) 10 markers highly differentiated
between Spanish and European American populations [31]. (viii) 12
markers from the LCT gene and MATP, OCA2, TYRP1, SLC24A5 and
MYO5A pigmentation genes [30,32,33,7]. Markers which failed primer
design or genotyping assay were excluded, yielding a list of 583
putatively ancestry-informative markers.
Dataset of 667 European samples from seven countries. The sample
collection was assembled on two plates. The ﬁrst plate included 60
samples from Sweden [34], 60 UK samples from the European
Collection of Cell Cultures (ECACC), 60 Polish samples collected by
Genomics Collaborative [1], 60 samples from southern Spain and 43
samples from southern Italy [35]. The second plate included 120
additional samples from Sweden, 22 additional UK samples, 81
additional samples from southern Italy, 80 samples from Greece [36]
and 81 Ashkenazi Jewish samples from Israel reporting four Jewish
grandparents, each born in central or eastern Europe. Genotyping
was performed using both the homogeneous MassEXTEND (hME)
and iPLEX assays for the Sequenom MassARRAY platform [37]. We
genotyped an initial set of 50 markers using the hME assay; for
greater efﬁciency, we used the iPLEX assay to genotype the remaining
markers (http://www.sequenom.com/seq_genotyping.html). We de-
signed primers using the Sequenom software, MassARRAY Assay
Design. We restricted subsequent analysis to markers that genotyped
successfully in .85% of samples and had 1 or fewer discrepancies
between replicate samples. We excluded markers with Hardy-
Weinberg P-values less than 0.01 in more than one ethnic group.
Dataset of 368 European American samples. The samples were
collected by Genomics Collaborative/SeraCare, as described previ-
ously [1]. Genotyping and quality control were performed as
described above.
Panel of 300 validated markers. Deﬁning clusters 1, 2 and 3 as
described (see Results), we computed FST(1,2) and FST(2,3) for each
marker passing quality control ﬁlters. Due to the limited representa-
tion of clusters 2 and 3 on the ﬁrst plate and to minimize differential
bias and differences in quality control ﬁlters between plates, only the
second plate of European samples was used. We ﬁrst selected 100
markers with the highest FST(1,2) and subsequently selected 200
markers with the highest FST(2,3), and required that each marker be
located at least 1Mb from each previously selected marker. The
number of markers from each ascertainment source that were
included in the ﬁnal panel of 300 markers is reported in Table S1.
Estimates of FST that account for upward bias. FST values for the
panel of 300 markers are biased upward since they were computed
using the same samples that we used to select the 300 markers. We
computed unbiased estimates of the value of FST for these markers by
dividing the samples into four quartiles, with the same distribution of
ancestries in each quartile. For each quartile, we selected 300 markers
as described above using only samples from the remaining quartiles,
then used samples from that quartile to compute unbiased FST values,
and averaged the results across quartiles. FST computations were
performed using the EIGENSOFT software, which fully accounts for
differences in sample size [11].
Stratiﬁcation correction of height samples. We applied the
EIGENSTRAT program [9] with default parameters to infer axes of
variation of a combined dataset of height samples and the second
plate of European samples (see above), using those axes of variation
to correct for stratiﬁcation in the height samples.
Web resources. http://genepath.med.harvard.edu/;reich/
EUROSNP.htm (panel of 300 markers).
Supporting Information
Figure S1. The Top Two Axes of Variation of MS, BD, PD, and IBD
Datasets
Samples are labeled based on cluster assignments inferred from
combined dataset (see text).
Found at doi:10.1371/journal.pgen.0030236.sg001 (1.7 MB PDF).
Figure S2. The Top Two Axes of Variation of HapMap Samples, Using
Genotype Data from Our Panel of 300 Markers
Found at doi:10.1371/journal.pgen.0030236.sg002 (96 KB PDF).
Table S1. Number of Markers from Each Ascertainment Source
Found at doi:10.1371/journal.pgen.0030236.st001 (35 KB DOC).
Table S2. In-Sample versus Out-of-Sample Stratiﬁcation Score
Approaches with Height As Phenotype
Found at doi:10.1371/journal.pgen.0030236.st002 (31 KB DOC).
Table S3. In-Sample versus Out-of-Sample Stratiﬁcation Score
Approaches with Gender as Phenotype
Found at doi:10.1371/journal.pgen.0030236.st003 (32 KB DOC).
Text S1. Supplementary Note
Found at doi:10.1371/journal.pgen.0030236.sd001 (43 KB DOC).
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